Arkolith/Insider Trading/KRON/Form 4

Olek Elizabeth A

SR VP, CLINICAL SCIENCEKronos Bio, Inc. (KRON) · full profile →Form 4 · filed Feb 23, 2024
Net Selling
Open-Market Buys
$0
Open-Market Sells
$8K
Net Open-Market Flow
-$8K
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Feb 21, 2024Sell(S)7K$1.05$8K193K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001415889-24-005151) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML